A wellness approach to addressing tobacco in mental health settings: Learning about healthy living

American Journal of Psychiatric Rehabilitation

Volumn 12, Issue 4, 2009, Pages 352-369

  Williams, Jill M ^a,b   Ziedonis, Douglas M ^c   Vreeland, Betty ^a,d   Speelman Edwards, Nancy ^b   Zechner, Michelle R ^e   Williams, Mark T ^d   Rahim, Raquel ^d   Karimi, Linda ^d   Molnar, Margaret ^f   Eilers, Robert ^f  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Environmental and Occupational Health   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d University of Medicine and Dentistry of New Jersey   (United States)

^e UMDNJ School of Health Related Professions   (United States)

^f New Jersey Department of Human Services   (United States)

Author keywords

Group treatment; Healthy living; Serious mental illness; Tobacco

Indexed keywords

EID: 85011249874     PISSN: 15487768     EISSN: 15487776     Source Type: Journal    
DOI: 10.1080/15487760903248580     Document Type: Article

References (50)

1. Addington, J., & el-Guebaly, N. (1998). Group treatment for substance abuse in schizophrenia. Canadian Journal of Psychiatry, 43(8), 843–845.
2. Beckham, J. C., Davidson, J. R. T., & March, J. S. (2003). Traumatic stress disorders. In M. First (Ed.), Psychiatry. New York: John Wiley & Sons.
3. Breslau, N., Davis, G. C., & Schultz, L. R. (2003). Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Archives of General Psychiatry, 60(3), 289–294.
4. Breslau, N., Novak, S. P., & Kessler, R. C. (2004). Psychiatric disorders and stages of smoking. Biological Psychiatry, 55(1), 69–76.
5. Carosella, A., Ossip-Klein, D. J., & Owens, C. A. (1999). Smoking attitudes, beliefs, and readiness to change among acute and long term care inpatients with psychiatric diagnoses. Addictive Behaviors, 24(3), 331–344.
6. Conners, C. K., Levin, E. D., Sparrow, E., Hinton, S., Ernhard, D., Meck, W. H., Rose, J. E., & March, J. (1996). Nicotine and attention in adult ADHD. Psychopharmacology Bulletin, 32(1), 67–73.
7. Covey, L. S., Hughes, D. C., Glassman, A. H., Blazer, D. G., & George, L. K. (1994). Ever-smoking, quitting, and psychiatric disorders: Evidence from the Durham, North Carolina, Epidemiologic Catchment Area. Tobacco Control, 3, 222–227.
8. de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76(2–3), 135–157.
9. Desai, H. D., Seabolt, J., & Jann, M. W. (2001). Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective. CNS Drugs, 15(6), 469–494.
10. Evins, A. E., Cather, C., Deckersbach, T., Freudenreich, O., Culhane, M. A., Olm-Shipman, C., et al. (2005). A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology, 25(3), 218–225.
11. Fiore, M. C., Bailey, W. C., & Cohen, S. J. (2000). Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service.
12. George, T. P., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J., & Kosten, T. R. (2002a). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52(1), 53–61.
13. George, T. P., Vessicchio, J. C., Termine, A., Sahady, D. M., Head, C. A., Pepper, W. T., et al. (2002b). Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology, 26(1), 75–85.
14. George, T. P., Ziedonis, D. M., Feingold, A., Pepper, W. T., Satterburg, C. A., Winkel, J., et al. (2000). Nicotine transdermal patch and atypical antipsychotic drugs for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835–1842.
15. Glassman, A. H. (1998). Psychiatry and cigarettes. Archives of General Psychiatry, 55(8), 692–693.
16. Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., et al. (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 80(1), 45–53.
17. Gonzalez-Pinto, A., Gutierrez, M., Ezcurra, J., Aizpuru, F., Mosquera, F., Lopez, P., et al. (1998). Tobacco smoking and bipolar disorder. Journal of Clinical Psychiatry, 59(5), 225–228.
18. Hall, R. G., DuHamel, M., McClanahan, R., Miles, G., Nason, C., Rosen, S., et al. (1995). Level of functioning, severity of illness, and smoking status among chronic psychiatric patients. Journal of Nervous and Mental Disease, 183, 468–471.
19. Hall, S. M., Munoz, R. F., Reus, V. I., Sees, K. L., Duncan, C., Humfleet, G. L., et al. (1996). Mood management and nicotine gum in smoking treatment: A therapeutic contact and placebo controlled study. Journal of Consulting and Clinical Psychology, 64(5), 1003–1009.
20. Hughes, J. R., Hatsukami, D. K., Mitchell, J. E., & Dahlgren, L. A. (1986). Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry, 143, 993–997.
21. Kelly, C., & McCreadie, R. G. (1999). Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry, 156, 1751–1757.
22. Lasser, K., Wesley, B. J., Woolhandler, S., Himmestein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A population-based prevalence study. Journal of the American Medical Association, 284, 2606–2610.
23. Lawn, S. J. (2004). Systemic barriers to quitting smoking among institutionalized public mental health service populations: A comparison of two Australian sites. International Journal of Social Psychiatry, 50(3), 204–215.
24. Levin, E. D., Conners, C. K., Silva, D., Canu, W., & March, J. (2001). Effects of chronic nicotine and methylphenidate in adults with attention deficit=hyperactivity disorder. Experimental and Clinical Psychopharmacology, 9(1), 83–91.
25. Lichtermann, D., Ekelund, J., Pukkala, E., Tanskanen, A., Lonnqvist, J. (2001). Incidence of cancer among persons with schizophrenia and their relatives. Archives of General Psychiatry, 58(6), 573–578.
26. McChargue, D. E., Gulliver, S. B., & Hitsman, B. (2002). Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment? Addiction, 97(7), 785–793.
27. McFall, M., Saxon, A. J., Thompson, C. E., Yoshimoto, D., Malte, C., Straits-Troster, K., et al. (2005). Improving the rates of quitting smoking for veterans with posttraumatic stress disorder. American Journal of Psychiatry, 162(7), 1311–1319.
28. Menza, M., Vreeland, B., Minsky, S., Gara, M., Radler, D. R., & Sakowitz, M. (2004). Managing atypical antipsychotic-associated weight gain: 12 month data on a multimodal weight control program. Journal of Clinical Psychiatry, 65(4), 471–477.
29. Montoya, I. D., Herbeck, D. M., Svikis, D. S., & Pincus, H. A. (2005). Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice. American Journal of Addictions, 14(5), 441–454.
30. Morbidity and Mortality Weekly Report. (2003). Cigarette smoking-attributable morbidity–United States, 2000. Morbidity and mortality weekly report, 52(35), 842–844.
31. National Association of State Mental Health Program Directors (NASMHPD), Medical Directors Council. (2006). Morbidity and Mortality in People with Serious Mental Illness. 13th Technical Report. October 2006.
32. Olincy, A., Ross, R. G., Young, D. A., Roath, M., & Freedman, R. (1998). Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology, 18(3), 175–185.
33. Pelletier, J. R., Nguyen, M., Bradley, K., Johnsen, M., & McKay, C. (2005). A study of a structured exercise program with members of an ICCD Certified Clubhouse: Program design, benefits, and implications for feasibility. Psychiatric Rehabilitation Journal, 29(2), 89–96.
34. Peterson, A. L., Hryshko-Mullen, A. S., & Cortez, Y. (2003). Assessment and diagnosis of nicotine dependence in mental health settings. American Journal of Addictions, 12(3), 192–197.
35. Sacco, K. A., Termine, A., Seyal, A., Dudas, M. M., Vessicchio, J. C., Krishnan-Sarin, S., et al. (2005). Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: Involvement of nicotinic receptor mechanisms. Archives of General Psychiatry, 62(6), 649–659.
36. SAMHSA Report to Congress on the Prevention and Treatment of Co-Occurring Substance Abuse Disorders and Mental Disorders. (2002). Washington, DC: Substance Abuse and Mental Health Services Administration=US Department of Health and Human Services.
37. Sherwood, N. E., Hennrikus, D. J., Jeffery, R. W., Lando, H. A., & Murray, D. M. (2000). Smokers with multiple behavioral risk factors: How are they different? Preventive Medicine, 31(4), 299–307.
38. Smith, R. C., Singh, A., Infante, M., Khandat, A., & Kloos, A. (2002). Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology, 27(3), 479–497.
39. Steinberg, M. L., Williams, J. M., & Ziedonis, D. M. (2004b). Financial implications of cigarette smoking among individuals with schizophrenia. Tobacco Control, 13(2), 206.
40. Steinberg, M. L., Ziedonis, D. M., Krejci, J. A., & Brandon, T. H. (2004a). Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psychology, 72(4), 723–728.
41. Stroup, T. S., Gilmore, J. H., & Jarskog, L. F. (2000). Management of medical illness in persons with schizophrenia. Psychiatric Annals, 30(1), 35–40.
42. Vanable, P. A., Carey, M. P., Carey, K. B., & Maisto, S. A. (2003). Smoking among psychiatric outpatients: Relationship to substance use, diagnosis, and illness severity. Psychology of Addictive Behaviors, 17(4), 259–265.
43. Vreeland, B., & Kim, E. (2004). Moving lives forward: Managing the consequences of obesity, diabetes, and hyperprolactinemia. Journal of the American Psychiatric Nurses Association, 10(3), S17–S24.
44. Vreeland, B., Minsky, S., Menza, M., Rigassio Radler, D., Roemheld-Hamm, B., & Stern, R. (2003). A program for managing weight gain associated with atypical antipsychotics. Psychiatric Services, 54(8), 1155–1157.
45. Williams, J. M. (2007). Using peer counselors to address tobacco: The CHOICES program. Psychiatric Services, 58(9), 1225.
46. Williams, J. M., & Hughes, J. R. (2003). Pharmacotherapy treatments for tobacco dependence among smokers with mental illness or addiction. Psychiatric Annals, 22(7), 457–466.
47. Williams, J. M., Steinberg, M. L., Hanos Zimmerman, M., Gandhi, K. K., Lucas, G. E., Gonsalves, D. A., Pearlstein, I., McCabe, P., Galazyn, M., & Salsberg, E. (2009). Training psychiatrists and advanced practice nurses to treat tobacco dependence. Journal of the American Psychiatric Nurses Association, 159(1), 50–58.
48. Williams, J. M., Ziedonis, D. M., & Foulds, J. (2004). Case series of nicotine nasal spray in the combination treatment of tobacco dependence among patients with schizophrenia. Psychiatric Services, 55(9), 1064–1066.
49. Ziedonis, D. M., & Trudeau, K. (1997). Motivation to quit using substances among individuals with Schizophrenia: Implications for a motivation-based treatment model. Schizophrenia Bulletin, 23(2), 229–238.
50. Ziedonis, D. M., & George, T. P. (1997). Schizophrenia and nicotine use: Report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophrenia Bulletin, 23(2), 247–254.